These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38327022)

  • 21. Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life.
    Morrisroe K; Sudararajan V; Stevens W; Sahhar J; Zochling J; Roddy J; Proudman S; Nikpour M
    Rheumatology (Oxford); 2018 Jan; 57(1):73-83. PubMed ID: 29155994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arthritis in patients with systemic sclerosis.
    Schmeiser T; Pons-Kühnemann J; Özden F; Müller-Ladner U; Dinser R
    Eur J Intern Med; 2012 Jan; 23(1):e25-9. PubMed ID: 22153544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of sociodemographic and disease variables with hand function: a Scleroderma Patient-centered Intervention Network cohort study.
    Kwakkenbos L; Sanchez TA; Turner KA; Mouthon L; Carrier ME; Hudson M; van den Ende CHM; Schouffoer AA; Welling JJKC; Sauvé M; Thombs BD;
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):88-94. PubMed ID: 30277865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population.
    Baron M; Hudson M; Tatibouet S; Steele R; Lo E; Gravel S; Gyger G; El Sayegh T; Pope J; Fontaine A; Masseto A; Matthews D; Sutton E; Thie N; Jones N; Copete M; Kolbinson D; Markland J; Nogueira-Filho G; Robinson D; Gornitsky M
    Rheumatology (Oxford); 2014 Aug; 53(8):1386-94. PubMed ID: 24464709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
    Park EH; Strand V; Oh YJ; Song YW; Lee EB
    Arthritis Res Ther; 2019 Feb; 21(1):61. PubMed ID: 30770765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclinical coronary atherosclerosis, detected by computer tomography with coronary calcium score, and the occurrence of major cardiovascular events at 5 years of follow-up in a cohort of patients with systemic sclerosis.
    Rotondo C; Sciacca S; Rella V; Busto G; Colia R; Cantatore FP; Corrado A
    Eur J Intern Med; 2023 Sep; 115():62-69. PubMed ID: 37316356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
    Jung M; Bonner A; Hudson M; Baron M; Pope JE;
    Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
    Fairley JL; Hansen D; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Morrisroe K; Ferdowsi N; Major G; Roddy J; Stevens W; Nikpour M;
    Arthritis Care Res (Hoboken); 2021 May; 73(5):732-741. PubMed ID: 32058672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
    Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
    Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis.
    Stamenković B; Stanković A; Dimić A; Damjanov N; Nedović J; Stojanović S; Savić V; Djordjević D
    Srp Arh Celok Lek; 2012; 140(5-6):350-4. PubMed ID: 22826990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Pain Characteristics in Patients with Rheumatoid Arthritis and Systemic Sclerosis with Particular Reference to the Neuropathic Pain Component: Cross-Sectional Study.
    Cengiz G; Erol K; Gok K; Ozgocmen S
    Med Princ Pract; 2018; 27(6):537-542. PubMed ID: 30184532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis.
    Steen VD; Medsger TA
    Arthritis Rheum; 1997 Jun; 40(6):1146-51. PubMed ID: 9182926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proximal weakness and creatine kinase elevation in systemic sclerosis: Clinical correlates, prognosis and functional implications.
    Fairley JL; Hansen D; Day J; Proudman S; Sahhar J; Ngian GS; Walker J; Host LV; Morrisroe K; Stevens W; Ross L; Nikpour M
    Semin Arthritis Rheum; 2024 Apr; 65():152363. PubMed ID: 38316069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review.
    Muangchan C; ; Baron M; Pope J
    J Rheumatol; 2013 Sep; 40(9):1545-56. PubMed ID: 23858045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden.
    Morrisroe K; Stevens W; Sahhar J; Ngian GS; Ferdowsi N; Hill CL; Roddy J; Walker J; Proudman S; Nikpour M
    Arthritis Res Ther; 2019 Dec; 21(1):299. PubMed ID: 31870459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil.
    Skare TL; Fonseca AE; Luciano AC; Azevedo PM
    An Bras Dermatol; 2011; 86(6):1075-81. PubMed ID: 22281893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and serological hallmarks of systemic sclerosis overlap syndromes.
    Pakozdi A; Nihtyanova S; Moinzadeh P; Ong VH; Black CM; Denton CP
    J Rheumatol; 2011 Nov; 38(11):2406-9. PubMed ID: 21844148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.